Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Stefan Lujinschi

Clinical trials sponsored by Stefan Lujinschi, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Fluid overload hides true lung pressure in dialysis patients, study aims to unmask it Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 1

Kidney hope: drug combo may slow alport disease

Disease control Completed

This completed Phase 4 trial tested two drugs—dapagliflozin and spironolactone—alone and together in 12 adults with Alport syndrome, a genetic kidney disease. The goal was to see if these drugs could lower protein levels in urine, a key sign of kidney damage. Participants took ea…

Phase 4 • Sponsor: Stefan Lujinschi • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC